Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Cisco's AI-Push Aids Networking Revenue: Is There More Upside Ahead?Photo, wide shot, wide-angle lens,  Artificial intelligence developer, sunset photo at golden hour, photo by Art Wolfe: https://img.theapi.app/temp/12e2798a-1095-4653-8f49-2a7aee633b4e.png
Cisco's AI-Push Aids Networking Revenue: Is There More Upside Ahead?

Cisco Systems’ CSCO first-quarter fiscal 2026 networking revenues increased 15% on a year-over-year basis to $7.77 billion, driven by robust demand for AI infrastructure and campus networking

Broadcom's Semiconductor Growth Picks Up: A Sign of More Upside?Photo, wide shot, wide-angle lens,  Consumer electronics manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/0defe5ca-333a-451e-9549-4f262e278fc7.png
Broadcom's Semiconductor Growth Picks Up: A Sign of More Upside?

Broadcom’s AVGO Semiconductor revenues are benefiting from strong demand for XPUs, which are a type of application-specific integrated circuit (ASIC) necessary to train Generative AI (Gen AI)

BRK.B Stock Moves Above 50- & 200-Day SMA: Buy, Sell or Stay Invested?
BRK.B Stock Moves Above 50- & 200-Day SMA: Buy, Sell or Stay Invested?

Shares of Berkshire Hathaway Inc. BRK.B have gained momentum recently. The stock moved above its 50- as well as 200-day simple moving average (SMA) on Dec. 22, signaling a bullish trend.The 50-day

Top-Performing International ETFs of 2025
Top-Performing International ETFs of 2025

Wall Street experienced quite a volatility in 2025, while international markets remained relatively stable or gained momentum. Trade uncertainty under the Trump U.S. administration has fueled

Santa Rally for Metal ETFs as Gold, Silver & Platinum Hit Highs: https://pixabay.com/de/photos/gold-ingots-golden-schatz-513062/
Santa Rally for Metal ETFs as Gold, Silver & Platinum Hit Highs

Precious metals rallied to record highs ahead of Christmas. Gold edged past the $4,500-per-ounce mark for the first time on Wednesday, while silver and platinum also touched fresh all-time highs, as

Sandisk Stock Rides on Datacenter Growth: A Sign of More Upside?
Sandisk Stock Rides on Datacenter Growth: A Sign of More Upside?

Sandisk SNDK is riding on strong datacenter revenue growth, which increased 26% sequentially in the first quarter of fiscal 2026, driven by strong demand for the “Stargate” product line. Growing

4 Drug, Biotech Stocks Rising More Than 50% in 2025 With Room to GrowPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
4 Drug, Biotech Stocks Rising More Than 50% in 2025 With Room to Grow

The drug and biotech sector witnessed a see-saw performance in 2025. After a weak show for most of the year, the sector picked up in the past couple of months. This can be attributed to improved

Lumentum Stock Rides on Strong AI Push: A Sign of More Upside?Photo, wide shot, wide-angle lens,  Cloud computing provider, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/8d7b6619-8b3b-4e9e-b659-68643d72528e.png
Lumentum Stock Rides on Strong AI Push: A Sign of More Upside?

Lumentum LITE is riding on strong AI demand, which is driving the need for its laser chips and optical transceivers inside data centers, as well as in the interconnect and long-haul networks that

NVO's First Oral Obesity Pill Approval: What Does it Mean for Lilly?
NVO's First Oral Obesity Pill Approval: What Does it Mean for Lilly?

Earlier this week, the FDA approved Eli Lilly and Company’s LLY rival Novo Nordisk’s NVO oral version of the obesity drug Wegovy (semaglutide). Wegovy is the first oral GLP-1 drug to be approved in

AI & Security Push Aids Google Cloud: What's Ahead for GOOGL Stock?Photo, wide shot, wide-angle lens,  Consumer electronics manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://img.theapi.app/temp/d8a4268f-c982-4aa8-a09e-f9ee1db62f57.png
AI & Security Push Aids Google Cloud: What's Ahead for GOOGL Stock?

Alphabet GOOGL is riding on a strong Google Cloud prospect, which accounts for more than 14% of GOOGL’s revenues. In the trailing nine-month period ended Sept. 30, Google Cloud revenues jumped 31.2%

4 Auto Stocks Up More Than 50% YTD & Still Worth Buying for 2026Photo, wide shot, wide-angle lens, soft focus,  Car manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-YEvJ4lsD0cnHYMSisqF0KmhC.png?st=2023-12-29T13%3A52%3A04Z&se=2023-12-29T15%3A52%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-12-29T03%3A19%3A21Z&ske=2023-12-30T03%3A19%3A21Z&sks=b&skv=2021-08-06&sig=cgEmp8qYLk6LiC9uwJEp9XOt32ky3AObpdzG41upqzc%3D
4 Auto Stocks Up More Than 50% YTD & Still Worth Buying for 2026

From tariff headlines to shifting EV incentives, the U.S. auto industry navigated sharp swings in sentiment and demand this year. Yet, despite the noise, consumer appetite for new vehicles has

Arkema Plans to Sell Plastic Additives Business to Praana
Arkema Plans to Sell Plastic Additives Business to Praana

Arkema S.A. ARKAY has announced a proposed sale of part of its impact modifiers business and processing aids to the Indian group Praana to streamline and increase focus on its strategic activities

Implied Volatility Surging for Ultra Clean Stock Options
Implied Volatility Surging for Ultra Clean Stock Options

Investors in Ultra Clean Holdings, Inc. UCTT need to pay close attention to the stock based on moves in the options market lately. That is because the March 20, 2026 $15.00 Call had some of the

Xmas Eve Jobless Claims: Still Accommodating
Xmas Eve Jobless Claims: Still Accommodating

Wednesday, December 24, 2025Pre-market futures are lower than yesterday’s close, which saw major indexes rise between +0.2% (Dow) and +0.6% (Nasdaq) on seasonal low volume (Xmas week), but hovering

Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know
Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know

Amgen AMGN recently signed a landmark agreement with the Trump administration to lower drug prices in the United States.

Through this deal, Amgen addresses the two major concerns that have plagued

Do Options Traders Know Something About Workiva Stock We Don't?
Do Options Traders Know Something About Workiva Stock We Don't?

Investors in Workiva Inc. WK need to pay close attention to the stock based on moves in the options market lately. That is because the Jan. 16, 2026 $40.00 Put had some of the highest implied

MRVL's Data Center Revenues Hit $1.5B: Can the Momentum Continue?
MRVL's Data Center Revenues Hit $1.5B: Can the Momentum Continue?

Marvell Technology MRVL posted strong results in the third quarter of fiscal 2026, which was led by its data center business. Revenues from the data center business reached $1.52 billion, up 38%

Best Momentum Stocks to Buy for Dec. 24Photo, wide shot, wide-angle lens,  Home appliance manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/5d70b6df-fa9b-4237-9702-39c36cb1d4f8.png
Best Momentum Stocks to Buy for Dec. 24

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Dec. 24th: 

Zumiez Inc. ZUMZ: This retail apparel and footwear company has a Zacks Rank #1

ArcelorMittal Announces Renewable Energy Projects in India
ArcelorMittal Announces Renewable Energy Projects in India

ArcelorMittal S.A. MT announced three new renewable energy projects in India, expanding its portfolio. The projects are expected to increase MT’s renewable energy capacity in India by two-fold to 2

Will Kodiak Collaboration Strengthen Verizon's Growth Prospects?Photo, wide shot, wide-angle lens,  Artificial intelligence developer, sunset photo at golden hour, photo by Art Wolfe: https://img.theapi.app/temp/12e2798a-1095-4653-8f49-2a7aee633b4e.png
Will Kodiak Collaboration Strengthen Verizon's Growth Prospects?

Verizon Communications Inc. (VZ) and Kodiak AI, Inc. (KDK) are working together to modernize the trucking industry by combining autonomous driving technology with advanced IoT and 5G connectivity.

CIFR or IREN: Which Bitcoin Miner Leads the AI Infrastructure Now?:
CIFR or IREN: Which Bitcoin Miner Leads the AI Infrastructure Now?

Cipher Mining CIFR and IREN Limited IREN are U.S.-based Bitcoin miners that began as pure-play miners, with revenues tightly linked to Bitcoin prices, network difficulty, and hash rate growth.Both

SMCI's Rack-Scale AI Strategy: Is it the Next Growth Engine?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.theapi.app/temp/012f8213-0bd1-4831-98f2-6d5fae956d6a.png
SMCI's Rack-Scale AI Strategy: Is it the Next Growth Engine?

Super Micro Computer SMCI in its first-quarter fiscal 2026 mentioned that it scaled up to an internal power capacity of 52 megawatts and is on track to scale up its rack capacity to 6,000 racks per

Sanofi to Buy Dynavax for $2.2B to Boost Adult Vaccine Franchise
Sanofi to Buy Dynavax for $2.2B to Boost Adult Vaccine Franchise

Sanofi SNY announced that it has entered into a definitive agreement to acquire Dynavax Technologies DVAX, a commercial-stage company, for $15.50 per share in cash, reflecting a total equity value

The Zacks Analyst Blog Highlights Hims & Hers Health, Biotricity and Privia Health
The Zacks Analyst Blog Highlights Hims & Hers Health, Biotricity and Privia Health

For Immediate Release

Chicago, IL – December 24, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Should You Buy X4 Pharmaceuticals (XFOR) After Golden Cross?Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Should You Buy X4 Pharmaceuticals (XFOR) After Golden Cross?

X4 Pharmaceuticals, Inc. (XFOR) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, XFOR's 50-day simple moving average crossed